Latest press releases Apr 10 2024 MoonLake Immunotherapeutics inks three-year technology partnership with Komodo Health to advance research on inflammatory skin and joint conditions Mar 10 2024 MoonLake announces significant improvements with Nanobody® sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day Mar 04 2024 MoonLake Immunotherapeutics to present MIRA trial data of Nanobody® sonelokimab in hidradenitis suppurativa as a late breaker at the AAD Annual Meeting 2024 View All News View All Press Releases + Upcoming events More events are coming soon. View All Events View All Events + Corporate presentations MoonLake R&D Day 10th March View All Presentations View All Presentations + IR contact details Dr. Atif Khan, Director of Strategic Planning and Projects e: ir@moonlaketx.com
Apr 10 2024 MoonLake Immunotherapeutics inks three-year technology partnership with Komodo Health to advance research on inflammatory skin and joint conditions
Mar 10 2024 MoonLake announces significant improvements with Nanobody® sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day
Mar 04 2024 MoonLake Immunotherapeutics to present MIRA trial data of Nanobody® sonelokimab in hidradenitis suppurativa as a late breaker at the AAD Annual Meeting 2024